ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1879

Artificial Intelligence for the Detection of Sacroiliitis on Magnetic Resonance Imaging in Patients with Axial Spondyloarthritis

Seulkee Lee1, Uju Jeon2, Ji Hyun Lee3, Seonyoung Kang1, Hyungjin Kim1, Jaejoon Lee1, Myung Jin Chung2, Jinseok Kim4, Eun-Mi Koh5 and Hoon-Suk Cha1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Medical AI Research Center, Samsung Medical Center, Seoul, South Korea, 3Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 4Department of Rheumatology, Jeju National University Hospital, Jeju National University School of Medicine, Jeju-si, Jeju-do, South Korea, La Jolla, CA, South Korea, 5Health Insurance Review and Assessment Service, Seoul, South Korea

Meeting: ACR Convergence 2023

Keywords: Magnetic resonance imaging (MRI), Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1862–1894) Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Magnetic resonance imaging (MRI) is important for the early detection of axial spondyloarthritis (axSpA). However, evaluation of sacroiliitis on MRI requires expertise because degenerative changes can mimic axSpA, and semiquantitative diagnosis remains subject to significant variation. Artificial intelligence (AI) has previously been applied to various MRI data including that of musculoskeletal system. Therefore, we developed an AI model for detecting in patients with axSpA, on MRI.

Methods: This study included MRI examinations of patients who underwent semi-coronal MRI scans of the sacroiliac joints owing to chronic back pain with short tau inversion recovery sequences between January 2010 and December 2021. Sacroiliitis was defined as a positive MRI finding according to the Assessment of Spondylo Arthritis international Society (ASAS) classification criteria for axSpA. The pipeline for the proposed automatic sacroiliitis classification method is shown in Figure 1. We developed a two-stage framework. First, the Faster R-CNN network extracted regions of interest (ROIs) to localize the sacroiliac joints. Maximum intensity projection (MIP) of three consecutive slices was used to mimic the reading of two adjacent slices. Second, the VGG-19 network determined the presence of sacroiliitis in localized ROIs. We augmented the positive dataset six-fold because of the smaller number of data points compared with the negative dataset. The sacroiliitis classification performance was measured using the accuracy and area under the receiver operating characteristic curve (AUROC). The prediction models were evaluated using three-round three-fold cross-validation.

Results: A total of 296 participants with 4,746 MRI slices were included. Sacroiliitis was identified in 864 MRI slices from 119 participants. The mean accuracy and AUROC for the detection of sacroiliitis were 89.8% (95% CI, 88.8%–90.8%) and 0.830 (95% CI, 0.792–0.868), respectively, at the image level and 79.4% (95% CI, 73.9%–84.9%) and 0.816 (95% CI, 0.776–0.856), respectively, at the patient level. The confusion matrices for the detection of sacroiliitis per image and subject are shown in Figure 2. In the original model, without using MIP and dataset augmentation, the mean accuracy and AUROC were 86.6% (95% CI, 85.4%–87.8%) and 0.731 (95% CI, 0.681–0.780), respectively, at the image level and 69.2% (95% CI, 62.7%–75.6%) and 0.711 (95% CI, 0.660–0.763), respectively, at the individual level (Table 1). Improved performances were observed compared with the original model.

Conclusion: An AI model was developed for the detection of sacroiliitis using MRI, compatible with the ASAS criteria for axSpA, with the potential to aid MRI application in a wider clinical setting.

Supporting image 1

Artificial intelligence framework to detect sacroiliitis in accordance with the Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis.

Supporting image 2

Confusion matrices of the first-round cross-validation using the proposed method (Method C) for detecting sacroiliitis (A) for individual MRI slices; (B) for each subject.

Supporting image 3

Performances of artificial intelligence models for the detection of sacroiliitis compatible with the Assessment of SpondyloArthritis international Society definition.


Disclosures: S. Lee: None; U. Jeon: None; J. Lee: None; S. Kang: None; H. Kim: None; J. Lee: None; M. Chung: None; J. Kim: None; E. Koh: None; H. Cha: None.

To cite this abstract in AMA style:

Lee S, Jeon U, Lee J, Kang S, Kim H, Lee J, Chung M, Kim J, Koh E, Cha H. Artificial Intelligence for the Detection of Sacroiliitis on Magnetic Resonance Imaging in Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/artificial-intelligence-for-the-detection-of-sacroiliitis-on-magnetic-resonance-imaging-in-patients-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/artificial-intelligence-for-the-detection-of-sacroiliitis-on-magnetic-resonance-imaging-in-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology